$AMRN #Amarin Please consider an objective clinical trial. You could have a group of patients with lower #triglyceride not taking anything but #Vascepa. Otherwise your top results have not value. Looks like you've meant #fabricating them from the word go #AHA18@US_FDA
@Amarincorp is feeding investors and community with the mouthwatering news. However, who can underwrite their objectiveness when #Amarin's trial is self-funded and conducted by its own employees? #biased $AMRN #ponzi#AHA18
Be aware of #fraudulent#offlabel promotion used by @Amarincorp. Topline results are based on a very narrow group of patients already medicated with statins and following a healthy diet. #Amarin had its clinical trial conducted by own employees, with huge grants to researchers
After its win against the @US_FDA to promote #Vascepa for #offlabel use, #Amarin gained access to sell its drug to a broader group of patients. So much broader that now it comprises half of the US population, who are now at risk of being fooled by #Amarin's false claims $AMRN
@Fractell358@FT Why people still trust the news? Some see an article bout TransEnterix CEO and ready to applause that crap, I see a #corrupted person in a bought article on @MarketWatch
Todd Pope has already earned money for himself?
But did you earn with $TRXC?
doubts
@jmcorzan @kdc415 @Fractell358@FT@YahooFinance And if you take a look at their buy&sell story here https://t.co/JJcyTs7VaB, you'll see that TRXC often buys AISLING CAPITAL III LP with each other.
AISLING was accused of fraud by @SEC couple years ago. Lovely couple I guess )
#avoid#scammers !
@TransEnterix @TIME Wonder how did you pay for that article that makes no sense )
1 mil? More? )
If there would be a 50 Most Influential #Cheaters in Healthcare, you'd be on the top )